31. Characteristics of doctor-shoppers: a systematic literature review. Issue 1 (1st January 2019) Authors: Biernikiewicz, Małgorzata; Taieb, Vanessa; Toumi, Mondher Journal: Journal of market access & health policy Issue: Volume 7:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
32. Chinese guidelines related to novel coronavirus pneumonia. Issue 1 (1st January 2020) Authors: Qiu, Tingting; Liang, Shuyao; Dabbous, Monique; Wang, Yitong; Han, Ru; Toumi, Mondher Journal: Journal of market access & health policy Issue: Volume 8:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
33. Clinical efficacy assessment in severe vernal keratoconjunctivitis: preliminary validation of a new penalties-adjusted corneal fluorescein staining score. Issue 1 (1st January 2020) Authors: Leonardi, Andrea; Dupuis-Deniaud, Maëva; Bremond-Gignac, Dominique Journal: Journal of market access & health policy Issue: Volume 8:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
34. Commentary on "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial" by Gautret et al. Issue 1 (1st January 2020) Authors: Toumi, Mondher; Aballea, Samuel Journal: Journal of market access & health policy Issue: Volume 8:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
35. Comparison of health technology assessment for new medicines in France and England: an example based on ixazomib for patients with relapsed or refractory multiple myeloma. Issue 1 (1st January 2019) Authors: Armoiry, Xavier; Spath, Hans-Martin; Clarke, Aileen; Connock, Martin; Sutcliffe, Paul; Dussart, Claude Journal: Journal of market access & health policy Issue: Volume 7:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
36. CORRECTION. Issue 1 (1st January 2019) Journal: Journal of market access & health policy Issue: Volume 7:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
37. Correction. Issue 1 (1st January 2019) Journal: Journal of market access & health policy Issue: Volume 7:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
38. Cost comparison of adverse event management among breast and ovarian cancer patients treated with poly (ADP-ribose) polymerase inhibitors: analysis based on phase 3 clinical trials. Issue 1 (31st December 2022) Authors: Fan, Lin; Zhang, Yuanyuan; Maguire, Peter; Muston, Dominic; Monberg, Matthew; Earla, Jagadeswara Rao; Mihai, Adela; Gulati, Poonam Journal: Journal of market access & health policy Issue: Volume 10:Issue 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
39. Cost-Effectiveness Analysis of a Prescription Digital Therapeutic for the Treatment of Opioid Use Disorder. Issue 1 (1st January 2021) Authors: Velez, Fulton F.; Malone, Daniel C. Journal: Journal of market access & health policy Issue: Volume 9:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
40. Cost-effectiveness analysis of ibrutinib in patients with Waldenström macroglobulinemia in Italy. Issue 1 (1st January 2017) Authors: Aiello, Andrea; D'Ausilio, Anna; Lo Muto, Roberta; Randon, Francesca; Laurenti, Luca Journal: Journal of market access & health policy Issue: Volume 5:Issue 1(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗